Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Finished Goods (2016)

Rockwell Medical filings provide 6 years of Finished Goods readings, the most recent being $3.0 million for Q3 2016.

  • On a quarterly basis, Finished Goods rose 41.85% to $3.0 million in Q3 2016 year-over-year; TTM through Sep 2016 was $3.0 million, a 41.85% increase, with the full-year FY2015 number at $2.2 million, up 44.24% from a year prior.
  • Finished Goods hit $3.0 million in Q3 2016 for Rockwell Medical, up from $2.8 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $3.0 million in Q3 2016 to a low of $1.4 million in Q2 2014.
  • Median Finished Goods over the past 5 years was $1.5 million (2014), compared with a mean of $1.8 million.
  • Biggest five-year swings in Finished Goods: dropped 8.83% in 2014 and later soared 77.77% in 2016.
  • Rockwell Medical's Finished Goods stood at $1.5 million in 2012, then decreased by 3.37% to $1.4 million in 2013, then increased by 8.83% to $1.5 million in 2014, then skyrocketed by 44.24% to $2.2 million in 2015, then surged by 36.02% to $3.0 million in 2016.
  • The last three reported values for Finished Goods were $3.0 million (Q3 2016), $2.8 million (Q2 2016), and $2.3 million (Q1 2016) per Business Quant data.